Alexion Pharmaceuticals - Archives

2007 Archives

PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity

Tuesday, December 11, 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH

Monday, December 10, 2007
^® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting"> Alexion Pharmaceuticals to Present Data on Soliris^® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting

Friday, December 7, 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients

Tuesday, December 4, 2007
Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting

Friday, November 9, 2007
Alexion to Present at Investor Conferences

Tuesday, November 6, 2007
Alexion Reports Third Quarter 2007 Results

Thursday, October 25, 2007
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast

Thursday, October 11, 2007
Alexion to Present at Bear Stearns Healthcare Conference

Tuesday, September 4, 2007
^™ Experienced Dramatic Reduction in Blood Clots During Clinical Trials"> PNH Patients Treated with Soliris^™ Experienced Dramatic Reduction in Blood Clots During Clinical Trials

Monday, August 20, 2007
Alexion Reports Second Quarter 2007 Results

Wednesday, July 25, 2007
Alexion Pharmaceuticals Invites You to Participate in its Second Quarter Results Conference Call and Web Cast

Thursday, July 12, 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH

Friday, June 22, 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH

Friday, June 22, 2007
Alexion to Present at the William Blair 27th Annual Growth Stock Conference

Wednesday, June 13, 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients

Monday, June 11, 2007
Alexion To Present At The Goldman Sachs 28th Annual Global Healthcare Conference

Tuesday, June 5, 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes

Monday, June 4, 2007
Alexion to Present at the Bank of America 2007 Health Care Conference

Friday, May 25, 2007
Alexion to Present at Citigroup's Global Healthcare Conference

Thursday, May 17, 2007
Alexion Pharmaceuticals Reports First Quarter 2007 Results

Tuesday, May 1, 2007
^™ in Europe"> CHMP Adopts Positive Opinion for Alexion's Soliris^™ in Europe

Friday, April 27, 2007
Alexion Pharmaceuticals Invites You to Participate in its First Quarter Results Conference Call and Web Cast

Friday, April 13, 2007
Alexion Pharmaceuticals to Hold Conference Call and Webcast

Thursday, March 22, 2007
^™ for All Patients With PNH"> Update: FDA Approves Alexion's Soliris^™ for All Patients With PNH

Monday, March 19, 2007
FDA Approves Alexion's Soliris(TM) for All Patients With PNH

Friday, March 16, 2007
Alexion Pharmaceuticals Reports Fourth Quarter and Year End 2006 Results

Thursday, February 15, 2007
Alexion To Present At The Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Tuesday, January 30, 2007
Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter Results Conference Call and Web Cast

Thursday, January 25, 2007
Alexion to Present at the Wachovia Securities 2007 Healthcare Conference

Wednesday, January 24, 2007
Alexion to Present at the 25th Annual JP Morgan Healthcare Conference

Tuesday, January 2, 2007